Article
Cancer and Tumour Suppressor p53 Encounters at the Juncture of Sex Disparity
16 Feb 2021
Abstract excerpt
There are many differences in cancer manifestation between men and women. New understanding of the origin of these point to fundamental distinctions in the genetic code and its demise. Tumour suppressor protein p53 is the chief operating officer of cancer defence and critically acts to safeguard against sustained DNA damaged. P53 cannot be ignored in cancer sex disparity. In this review we discuss the greater...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
